PACS NYSE Services-Skilled Nursing Care Facilities Financials FY2022βFY2025
PACS Group, Inc. had $5.3B of revenue in fiscal 2025, up 29.3% on the year before.
Last close Β· Oct 23, 2026
$47.64
0.3%Hi! I read PACS Group, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+29.3%
Yes. Sales grew 29.3% last year.
Does it make a profit?
3.6%
A little. It keeps 3.6% of every sale as profit.
How healthy are the accounts?
7 / 8
Solid. It passes 7 of 8 health tests.
How is the share priced?
27.9x
One share costs 27.9 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days PACS Group, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 18, 2026
Wednesday Β· in 23 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 4, 2026 | Q2 '26 | After the market closes | 8-K β |
| May 11, 2026 | Q1 '26 | After the market closes | 8-K β |
| Feb 26, 2026 | Q4 '25 | After the market closes | 8-K β |
| Nov 19, 2025 | Q3 '25 | After the market closes | 8-K β |
| Nov 19, 2025 | Q1 '25 | After the market closes | 10-Q β |
| Nov 19, 2025 | Q4 '24 | After the market closes | 10-K β |
| Sep 11, 2025 | Q2 '25 | Before the market opens | 8-K β |
| Nov 6, 2024 | Q3 '24 | Before the market opens | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· PACS Group, Inc. had $5.3B of revenue in fiscal 2025, up 29.3% on the year before. Its operating margin was 5.9%, up 2.8Β pts: of every 100 in sales, about 6 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· PACS Group, Inc. made $192M of net profit in fiscal 2025. From fiscal 2022 to 2025, diluted EPS grew 1.4% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· PACS Group, Inc. returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 5.5%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.5M and sold $83.4M of shares on the open market.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.5M
1 insider
Sold, 12 months
$83.4M
6 insiders
Of sales under plans
93%
$77.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 24,224 | $42.66 | $1.0M | Form 4 |
| Oct 2, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 26,052 | $42.51 | $1.1M | Form 4 |
| Oct 1, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 33,032 | $41.13 | $1.4M | Form 4 |
| Sep 16, 2026 | Joshua JergensenPresident & COO | Sold plan | 40,000 | $43.13 | $1.7M | Form 4 |
| Sep 15, 2026 | Mark HancockDirector, 10% owner | Sold plan | 155,682 | $42.47 | $6.6M | Form 4 |
| Sep 14, 2026 | Mark HancockDirector, 10% owner | Sold plan | 144,318 | $44.58 | $6.4M | Form 4 |
| Sep 14, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 317 | $45.03 | $0.0M | Form 4 |
| Sep 11, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 10,529 | $45.23 | $0.5M | Form 4 |
| Sep 10, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 8,771 | $45.16 | $0.4M | Form 4 |
| Sep 9, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 4,758 | $43.33 | $0.2M | Form 4 |
| Sep 8, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 24,057 | $43.49 | $1.0M | Form 4 |
| Sep 4, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 23,072 | $42.68 | $1.0M | Form 4 |
| Sep 3, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 20,173 | $42.55 | $0.9M | Form 4 |
| Sep 2, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 23,783 | $42.93 | $1.0M | Form 4 |
| Sep 1, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 24,157 | $42.39 | $1.0M | Form 4 |
| Aug 21, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 59,244 | $43.91 | $2.6M | Form 4 |
| Aug 20, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 91,306 | $43.92 | $4.0M | Form 4 |
| Aug 19, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 84,717 | $44.26 | $3.7M | Form 4 |
| Aug 18, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 66,797 | $44.18 | $3.0M | Form 4 |
| Aug 17, 2026 | Jason Hulse MurrayCo-Founder, CEO & Chairman, Director, 10% owner | Sold plan | 84,602 | $44.16 | $3.7M | Form 4 |
| Aug 14, 2026 | Patrick Hugh ConwayDirector | Sold | 3,497 | $44.41 | $0.2M | Form 4 |
| Aug 12, 2026 | Joshua JergensenPresident & COO | Sold plan | 40,000 | $45.59 | $1.8M | Form 4 |
| Jul 15, 2026 | Joshua JergensenPresident & COO | Sold plan | 40,000 | $45.02 | $1.8M | Form 4 |
| Jul 15, 2026 | Mark HancockDirector, 10% owner | Sold plan | 3,332 | $45.05 | $0.2M | Form 4 |
| Jul 14, 2026 | Mark HancockDirector, 10% owner | Sold plan | 10,296 | $45.04 | $0.5M | Form 4 |
| Jul 9, 2026 | Mark HancockDirector, 10% owner | Sold plan | 4,966 | $45.06 | $0.2M | Form 4 |
| Jul 8, 2026 | Mark HancockDirector, 10% owner | Sold plan | 20,338 | $45.07 | $0.9M | Form 4 |
| Jul 6, 2026 | Mark HancockDirector, 10% owner | Sold plan | 142,163 | $45.33 | $6.4M | Form 4 |
| Jul 6, 2026 | Michelle Renee LewisChief Accounting Officer | Sold plan | 4,137 | $45.04 | $0.2M | Form 4 |
| Jul 2, 2026 | Mark HancockDirector, 10% owner | Sold plan | 12,825 | $45.01 | $0.6M | Form 4 |
| Jul 2, 2026 | Michelle Renee LewisChief Accounting Officer | Sold plan | 6,663 | $45.03 | $0.3M | Form 4 |
| Jul 1, 2026 | Mark HancockDirector, 10% owner | Sold plan | 6,080 | $45.02 | $0.3M | Form 4 |
| Jul 1, 2026 | Michelle Renee LewisChief Accounting Officer | Sold plan | 4,200 | $45.01 | $0.2M | Form 4 |
| Jun 26, 2026 | Mark HancockCo Fndr; Exec V Chair, Director, 10% owner | Sold plan | 61,931 | $40.50 | $2.5M | Form 4 |
| Jun 25, 2026 | Mark HancockCo Fndr; Exec V Chair, Director, 10% owner | Sold plan | 138,069 | $40.33 | $5.6M | Form 4 |
| Jun 25, 2026 | Michelle Renee LewisChief Accounting Officer | Sold plan | 15,000 | $40.01 | $0.6M | Form 4 |
| Jun 17, 2026 | Mark HancockCo Fndr; Exec V Chair, Director, 10% owner | Sold plan | 63,680 | $35.30 | $2.2M | Form 4 |
| Jun 16, 2026 | Mark HancockCo Fndr; Exec V Chair, Director, 10% owner | Sold plan | 83,066 | $35.90 | $3.0M | Form 4 |
| Jun 15, 2026 | Mark HancockCo Fndr; Exec V Chair, Director, 10% owner | Sold plan | 153,254 | $36.33 | $5.6M | Form 4 |
| May 18, 2026 | John Todd MitchellChief Legal Officer & Sec. | Sold plan | 27,389 | $37.16 | $1.0M | Form 4 |
| May 15, 2026 | John Todd MitchellChief Legal Officer & Sec. | Sold plan | 52,763 | $38.02 | $2.0M | Form 4 |
| Mar 13, 2026 | Joshua JergensenPresident & COO | Sold | 36,335 | $34.28 | $1.2M | Form 4 |
| Nov 24, 2025 | John Todd MitchellChief Legal Officer & Sec. | Sold | 159,556 | $29.89 | $4.8M | Form 4 |
| Nov 24, 2025 | Evelyn S DilsaverDirector | Bought | 16,724 | $29.90 | $0.5M | Form 4 |
Can it carry its debts, and how well does it use its money?
KIRA Β· PACS Group, Inc. owes $312M more than it holds in cash.
Cash, debt and the ratios that show how comfortably PACS Group, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $58.3M | $73.4M | $158M | $197M |
| Debt incl. finance leases | β | $213M | $559M | $509M |
| Debt / equity | β | 2.2x | 0.6x | 0.4x |
| Interest coverage | 9.0x | 4.2x | 2.8x | 10.9x |
| Current ratio | β | 1.6x | 1.0x | 1.1x |
| Quick ratio | β | 1.6x | 1.0x | 1.1x |
| Total assets | β | $3.5B | $5.2B | $5.6B |
| Total liabilities | β | $3.4B | $4.5B | $4.6B |
| Shareholders' equity | $68.7M | $96.1M | $710M | $947M |
| Net debt (β = net cash) | β | $139M | $401M | $312M |
KIRA Β· Its return on capital was 18.9%: every 100 invested in the business earned about 19 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· PACS Group, Inc. passes 7 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 4 | 3 / 8 | 7 / 8 |
| Accruals ratio | β | 1.4% | β7.1% | β3.9% |
| Altman Z'' | β | 1.01 | 0.35 | 0.85 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.4B | $3.1B | $4.1B | $5.3B |
| Operating income | $229M | $208M | $123M | $310M |
| Interest expense | $25.5M | $49.9M | $44.3M | $28.4M |
| Pretax income | $207M | $157M | $102M | $284M |
| Income tax | $56.5M | $44.4M | $46.2M | $93.0M |
| Net income | $150M | $113M | $55.8M | $192M |
| Net income to common | $150M | $113M | $55.8M | $192M |
| Diluted EPS | $1.17 | $0.88 | $0.38 | $1.22 |
| Diluted shares | 0.13B | 0.13B | 0.15B | 0.16B |
| Cash flow | ||||
| Cash from operations | $92.6M | $63.7M | $367M | $404M |
| Stock-based compensation | $0.0M | $0.0M | $116M | $54.1M |
| Dividends paid | $60.3M | $80.4M | $33.7M | $0.0M |
| Dividends and buybacks | $60.3M | $80.4M | $33.7M | $0.0M |
| Balance sheet | ||||
| Cash and short-term investments | $58.3M | $73.4M | $158M | $197M |
| Total debt | β | $213M | $412M | $353M |
| Finance lease liabilities | β | β | $147M | $156M |
| Current assets | β | $722M | $938M | $1.1B |
| Current liabilities | β | $457M | $978M | $1.0B |
| Goodwill | $55.2M | $59.0M | $60.8M | $61.8M |
| Total assets | β | $3.5B | $5.2B | $5.6B |
| Total liabilities | β | $3.4B | $4.5B | $4.6B |
| Shareholders' equity | $68.7M | $96.1M | $710M | $947M |
| Margins | ||||
| Operating margin | 9.5% | 6.7% | 3.0% | 5.9% |
| Net margin | 6.2% | 3.6% | 1.4% | 3.6% |
| Returns | ||||
| Return on capital | β | 63.4% | 8.3% | 18.9% |
| Return on capital employed | β | 6.8% | 2.9% | 6.8% |
| Return on equity | 219.2% | 137.0% | 13.8% | 23.1% |
| Return on assets | β | 3.2% | 1.3% | 3.5% |
| Return on tangible equity | 1,120.6% | 304.2% | 8.6% | 21.6% |
| Growth | ||||
| Revenue growth | β | 28.5% | 31.4% | 29.3% |
| Net income growth | β | β25.0% | β50.6% | 243.5% |
| EPS growth | β | β24.8% | β56.8% | 221.1% |
| Share count change | β | 0.0% | 15.4% | 5.5% |
| Financial health | ||||
| Debt / equity | β | 2.2x | 0.6x | 0.4x |
| Interest coverage | 9.0x | 4.2x | 2.8x | 10.9x |
| Current ratio | β | 1.6x | 1.0x | 1.1x |
| Quick ratio | β | 1.6x | 1.0x | 1.1x |
| Capital allocation | ||||
| Stock comp / revenue | 0.0% | 0.0% | 2.8% | 1.0% |
| Quality scores | ||||
| Piotroski F-score | β | β | 3.0 | 7.0 |
| Altman Z'' | β | 1.0 | 0.3 | 0.8 |
| Accruals ratio | β | 1.4% | β7.1% | β3.9% |
Source: SEC EDGAR XBRL filings (CIK 0002001184). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
